Lv6
1672 积分 2022-07-18 加入
Discovery, preclinical development, and clinical application of pralsetinib in the treatment of thyroid cancer
5天前
已完结
Hair Depigmentation Is a Biological Readout for Pharmacological Inhibition of KIT in Mice and Humans
11天前
已完结
An update on lipophilic efficiency as an important metric in drug design
12天前
已完结
Urticaria
3个月前
已完结
Selective and Potent Molecular Glue Degraders for NIMA‐Related Kinase 7
3个月前
已完结
A cereblon-based glue degrader of NEK7 regulates NLRP3 inflammasome in a context-dependent manner
4个月前
已完结
Ofirnoflast: a first-in-class NEK7-targeted inhibitor of the NLRP3 inflammasome
4个月前
已完结
Selective and Potent Molecular Glue Degraders for NIMA‐related Kinase 7
4个月前
已完结
Why 90% of clinical drug development fails and how to improve it?
5个月前
已完结
Design and Synthesis of NTQ1062, a new Akt Inhibitor Clinical Candidate
5个月前
已完结
皖公网安备34019202002308
